Incomplete Kawasaki disease with recurrent skin peeling: a case report with the review of literature.
ABSTRACT Kawasaki disease (KD) is an acute systemic vasculitis of unknown aetiology that has largely replaced rheumatic heart disease as a cause of acquired heart disease in children of many developed countries. We report a case of incomplete KD in a five-year-old girl. The diagnosis of incomplete KD was made after exclusion of conditions with similar presentation. She was treated with intravenous immunoglobulin following which she made an uneventful recovery but demonstrated thrombocytosis in the second week of convalescence. During the six-month follow up period, she had two episodes of recurrent skin peeling a phenomenon, which is recently reported with KD but not with atypical or incomplete KD. It is important for the treating physicians to become aware of the incomplete KD as prompt diagnosis and early treatment of these patients with intravenous immunoglobulin is vital for the prevention of lethal coronary complications. Physicians need to have a "high index of suspicion" for KD and even, higher for IKD.
- SourceAvailable from: sciencedirect.com[Show abstract] [Hide abstract]
ABSTRACT: Kawasaki Disease (KD) is an acute systemic vasculitis of unknown etiology. In many developed countries, KD has replaced rheumatic heart disease as the leading cause of acquired heart disease in children. Among the classical criteria for a diagnosis of KD are oral manifestations such as strawberry tongue, erythematous cracked lip, and oropharyngeal mucositis. We report the case of a 24-year-old Saudi female with a history of Kawasaki disease who presented to our oral medicine clinic with recurrent painless swelling of the upper lip. As lip swelling has not previously been reported as an oral manifestation of KD, this case represents a novel presentation of recurrent Kawasaki disease in an adult female.Saudi Dental Journal 01/2013; 25(1):43-7.
Article: Models of Kawasaki disease[Show abstract] [Hide abstract]
ABSTRACT: Enitan Carrol – Malawi-Liverpool-Wellcome Trust Clinical Research, Blantyre and Liverpool, Malawi and UK Andrew Riordan – Birmingham Heartlands Hospital, Birmingham, UKDrug Discovery Today Disease Models 03/2006; 3(1):83-89.
- The Indian Journal of Pediatrics 06/2006; 73(6):546-546. · 0.72 Impact Factor